Pharmaceuticals, Biotechnology and Life Sciences
Roche on Wednesday reported 10% raise in sales in the third yearly quarter of 2019, backed by new products, while its Pharmaceuticals Division sales went up 12%, driven by high demand for recently launched medicines, mainly Ocrevus, Hemlibra, Tecentriq and Perjeta.
Shinogoi might have cefiderocol approved by the US FDA, as the Advisory Committee reccomends it for treatment of complicated urinary…
-Boehringer Ingelheim is enrolling first patient to test nvestigational compound BI ENaC inhibitor delivered twice daily via the Respimat, a…
CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC) a clinical-stage biotechnology company pioneering a new and differentiated class of…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional therapeutics, today announced the appointment of Kathryn…
TriPharm services creates Pharmaceutical manufacturing center to address Shortage of qualified parenteral manufacturing options in the U.S.
Amarna Therapeutics has raised €10 million in a round led by Swedish investor Flerie Invest AB with substantial contributions from…
Vaxess and GC Pharma will collaborate on Influenza vaccine smart release patch, in a deal which will give Vaxess exclusive…
Enzyvant appoints former COO of Compass and Horizon Discovery as Chief Operating Officer, as the company nears first potential drug…
Amphivena is set to move on with AMV564 in a Multi-Center Dose Finding Phase 1 Clinical Study in Patients with…